Skip to main content

NEOGEN CORP

corporate_fare Company Profile

NEOGEN CORP

NEOG·NASDAQ·Life Sciences·CIK 0000711377

Neogen Corporation develops, manufactures, and markets a diverse line of products and services focused on food and animal safety. Its Food Safety segment primarily offers diagnostic test kits and complementary products, such as culture media, to food and animal feed producers and processors. These products help preserve food safety and quality by preventing contamination and foodborne illnesses from pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products, and also ensure general hygiene in food manufacturing. The company also provides products to determine food quality and nutritional components. Most test kits are consumable, single-use, culture, immunoassay, and nucleic acid detection products utilizing proprietary antibodies and RNA and DNA testing methodologies for rapid and accurate results. Food safety services include advanced software systems for objective analysis, storage, and identification of emerging issues from test results across multiple locations over extended periods. On September 1, 2022, Neogen combined with 3M Company's Food Safety Division (FSD) in a Reverse Morris Trust transaction, with FSD products now reported in the Food Safety segment. Following this transaction, pre-merger Neogen Food Safety Corporation stockholders owned approximately 50.1% of Neogen common stock, and pre-merger Neogen shareholders owned approximately 49.9%. Neogen's Animal Safety segment develops, manufactures, markets, and distributes veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services for the worldwide animal safety market. Most of these consumable products are marketed through veterinarians, retailers, livestock producers, and animal health product distributors.

NEOGEN CORP (NASDAQ:NEOG) is a publicly traded company in the Life Sciences sector. Wiseek monitors NEOG SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Neogen Reports Wider Q3 GAAP Loss Amid Strategic Divestitures & Persistent Control Weaknesses
  • Neogen Beats Q3 Earnings & Revenue, Boosts Full-Year Outlook
  • Neogen Reports Mixed Q3, Raises FY26 Revenue Outlook, and Divests Genomics Business for $160M
  • Neogen's Chief Legal Officer Departs Amid Ongoing Legal Challenges
  • Neogen Sells Animal Genomics Business to Zoetis for $160 Million

Financial Snapshot

Fiscal year ended May 31, 2025
Revenue
$894.66M
Net Income
-$1.09B
Diluted EPS
-$5.03
Op. Cash Flow
$58.24M
Free Cash Flow
-$46.35M
Gross Profit
$421.38M
Operating Income
-$1.06B
Cash & Equivalents
$129M
Total Debt
$894.11M
Debt / Equity
0.43×
Net Margin
-122.1%
Shares Outstanding
216.61M sh
Source: 10-K · filed 2025-07-30 · accession 0000950170-25-100064
Browse all tickers starting with N →
$9.08 -0.02% today
52-week range · as of 2026-04-09 $3.87 – $11.43
Market cap
$1.98B
Volume
1.3M (0.5× avg)
3-mo avg 2.4M
Live data · 2026-06-14 05:13 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed NEOG - Latest Insights

NEOG
Apr 09, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $10.04
Real-time Price: $9.08 info
Change: -$0.955 (-10%) info
Market Cap: $1.981B info
NEOG
Apr 09, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $9.47
Real-time Price: $9.08 info
Change: -$0.390 (-4%) info
Market Cap: $1.981B info
NEOG
Apr 09, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.11
Real-time Price: $9.08 info
Change: -$1.03 (-10%) info
Market Cap: $1.981B info
NEOG
Mar 30, 2026, 8:19 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.80
Real-time Price: $9.08 info
Change: +$0.280 (+3%) info
Market Cap: $1.981B info
NEOG
Mar 02, 2026, 8:58 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $11.47
Real-time Price: $9.08 info
Change: -$2.39 (-21%) info
Market Cap: $1.981B info
NEOG
Jan 08, 2026, 4:07 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $9.65
Real-time Price: $9.08 info
Change: -$0.5701 (-6%) info
Market Cap: $1.981B info
NEOG
Jan 08, 2026, 7:03 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.32
Real-time Price: $9.08 info
Change: +$0.760 (+9%) info
Market Cap: $1.981B info